Regatta Capital Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$513K Sell
3,273
-147
-4% -$22K 0.07% 140
2026
Q1
$522K Sell
3,420
-906
-21% -$139K 0.08% 136
2025
Q4
$596K Sell
4,326
-59
-1% -$7.73K 0.09% 128
2025
Q3
$562K Sell
4,385
-123
-3% -$15K 0.09% 135
2025
Q2
$545K Buy
4,508
+117
+3% +$13.2K 0.09% 131
2025
Q1
$490K Sell
4,391
-20
-0.5% -$2.13K 0.09% 123
2024
Q4
$429K Sell
4,411
-69
-2% -$7.36K 0.08% 127
2024
Q3
$515K Buy
4,480
+3
+0.1% +$340 0.1% 117
2024
Q2
$477K Sell
4,477
-119
-3% -$11.9K 0.1% 118
2024
Q1
$445K Buy
4,596
+233
+5% +$23.9K 0.1% 125
2023
Q4
$441K Buy
4,363
+3
+0.1% +$290 0.12% 115
2023
Q3
$444K Sell
4,360
-7
-0.2% -$711 0.14% 104
2023
Q2
$441K Buy
4,367
+209
+5% +$20.9K 0.14% 111
2023
Q1
$377K Hold
4,158
0.13% 125
2022
Q4
$377K Sell
4,158
-79
-2% -$6.65K 0.13% 125
2022
Q3
$358K Buy
4,237
+533
+14% +$44.2K 0.15% 117
2022
Q2
$313K Sell
3,704
-1,656
-31% -$145K 0.15% 117
2022
Q1
$470K Buy
5,360
+8
+0.1% +$693 0.16% 103
2021
Q4
$468K Buy
+5,352
New +$444K 0.16% 108

Other funds holding NVS

Regatta Capital Group's NVS Position: Q2 2026 in Review

Regatta Capital Group reduced its Novartis (NVS) stake by 4.3% in Q2 2026, selling an estimated $22K and leaving 3,273 shares worth $513K. The position accounts for 0.07% of the portfolio, ranked #140.

Regatta Capital Group first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $596K in Q4 2025. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Regatta Capital Group held 3,273 shares of Novartis worth $513K as of Q2 2026.
  • Regatta Capital Group sold 147 Novartis shares in Q2 2026, an estimated $22K.
  • Novartis made up 0.07% of Regatta Capital Group's portfolio in Q2 2026, its #140 holding.
  • Regatta Capital Group first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
  • Regatta Capital Group's Novartis position peaked at $596K in Q4 2025.
  • 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Regatta Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.